Disorders of bone mineral homeostasis |
Rickets and osteomalacia [31] |
Impairment of mineral deposition |
Hyperparathyroidism [38] |
Excessive secretion of PTH, leading to increased osteoclastic bone resorption |
Hypogonadism [33, 37] |
Reduced sex hormones, resulting in increased osteoclastic bone resorption |
Hyperthyroidism [85] |
Increased bone resorption |
Type I diabetes mellitus [83] |
Suppression of bone turnover |
Cushing’s disease [51, 58, 106] |
See Glucocorticoids |
Imbalance of bone remodeling |
Renal osteodystrophy [98] |
Increased osteoclastic bone resorption in high turnover state or decreased bone formation in low turnover state |
Paget’s disease [81] |
Rapid bone turnover, leading to disorganized mosaic pattern of woven and lamellar bone |
Disuse osteoporosis [35, 110] |
Uncoupling between bone resorption and formation with increased in bone resorption |
Sclerosing bone dysplasias (osteopetrosis) [18, 105] |
Defects in osteoclastic bone resorption (retention of primary spongiosa) |
Disorders of collagen |
Osteogenesis imperfecta [6] |
Mutation of Type I collagen genes |
Scurvy [78] |
Impairment of hydroxylation process during collagen synthesis |
Marfan syndrome [40] |
Abnormalities of fibrillin-1 glycoprotein |
Ehlers-Danlos syndromes [13] |
Defects in lysyl hydroxylase and collagen type I, III, and V |
Drugs |
Glucocorticoids [51, 58, 106] |
Increased osteoclastic resorption, impaired maturation of osteoblasts and altered calcium metabolism |
Chemotherapeutic agents [49, 79] |
Hypogonadism or direct toxic effects on bone |
Disease modifying antirheumatic drugs (DMARDs) [26] |
Imbalance of bone turnover |
Bisphosphonates [76, 96] |
Suppression of osteoclastic activity, leading to microdamage accumulation |